Acadia snags Amgen, Horizon vet to direct R&D; Samantha Truex steps down as Upstream Bio CEO
→ Just a few weeks after Amgen touted its efforts in rare disease, EVP of R&D in that therapeutic …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
